Rakesh Garg
Payments from drug & device makers
Across 86 payments — averaging $27.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$319
- Teva Pharmaceuticals USA, Inc.$180
- UCB, Inc.$136
- Biogen$126
- Jazz Pharmaceuticals Inc.$121
- Lilly USA, LLC$112
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,28198%
- Education$452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 5 | $319 |
| Teva Pharmaceuticals USA, Inc. | 7 | $180 |
| UCB, Inc. | 4 | $136 |
| Biogen | 5 | $126 |
| Jazz Pharmaceuticals Inc. | 4 | $121 |
| Lilly USA, LLC | 5 | $112 |
| Supernus Pharmaceuticals, Inc. | 6 | $108 |
| Argenx US, Inc. | 4 | $102 |
| Aucta Pharmaceuticals, Inc. | 4 | $88 |
| Catalyst Pharmaceuticals, Inc. | 4 | $84 |
| Sanofi | 2 | $81 |
| AbbVie | 4 | $74 |
| Axsome Therapeutics, Inc. | 1 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Novartis | 3 | $64 |
| Johnson & Johnson | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Genentech USA, Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Bristol Myers Squibb | 1 | $33 |
| Lundbeck LLC | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Pfizer | 1 | $23 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Amgen | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Tanabe Pharma America, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Impel Pharmaceuticals LLC | 1 | $14 |
How this compares
$2,326 in reported general payments places this provider in the 60th percentile of 790 neurology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine ErCarbamazepine | 12 | $1,856 |
| Levetiracetam | 67 | $1,262 |
| Propranolol Hcl ErPropranolol Hcl | 18 | $1,205 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $1,058 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 78 | $837 |
| Pyridostigmine Bromide | 11 | $694 |
| Cyclobenzaprine Hcl | 15 | $596 |
| Lamotrigine | 33 | $557 |
| Donepezil Hcl | 77 | $461 |
| Clonidine | 12 | $299 |
| Clonazepam | 47 | $121 |
| Tizanidine Hcl | 13 | $105 |
| Pregabalin | 11 | $89 |
| Tramadol Hcl | 20 | $57 |
| Atorvastatin Calcium | 15 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $112 | $5014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 790 neurology providers in Illinois.
Other neurology in Peru
- Daniel WynnNorthbrook$13.9M
- Concetta ForchettiElk Grove Village$8.5M
- Tatyana SimuniChicago$3.5M
- Danny BegaChicago$2.8M
- Thomas AlaSpringfield$2.4M
- Augusto MiravalleChicago$2.1M
- Leonard Verhagen MetmanChicago$1.8M
- Anthony RederBurr Ridge$1.6M
- Dusan StefoskiChicago$1.5M
- Kourosh RezaniaChicago$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.